News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
193,708 Results
Type
Article (4956)
Company Profile (56)
Press Release (188691)
Multimedia
Podcasts (5)
Webinars (7)
Section
Business (53459)
Career Advice (297)
Deals (10923)
Drug Delivery (21)
Drug Development (9800)
Employer Resources (28)
FDA (5363)
Job Trends (4551)
News (81869)
Policy (6349)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (607)
Accelerated approval (3)
Allergies (40)
Alliances (18863)
ALS (29)
Alzheimer's disease (341)
Antibody-drug conjugate (ADC) (41)
Approvals (5544)
Artificial intelligence (296)
Autoimmune disease (23)
Automation (30)
Bankruptcy (79)
Best Places to Work (4181)
BIOSECURE Act (3)
Biosimilars (59)
Biotechnology (41)
Bladder cancer (46)
Brain cancer (11)
Breast cancer (129)
Cancer (967)
Cardiovascular disease (67)
Career advice (267)
Career pathing (10)
CAR-T (39)
CDC (1)
Cell therapy (146)
Cervical cancer (12)
Clinical research (8774)
Collaboration (760)
Compensation (120)
Complete response letters (7)
COVID-19 (527)
CRISPR (35)
C-suite (239)
Cystic fibrosis (11)
Data (1232)
Decentralized trials (2)
Denatured (5)
Depression (35)
Diabetes (111)
Diagnostics (3281)
Digital health (31)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (85)
Drug pricing (27)
Drug shortages (3)
Duchenne muscular dystrophy (13)
Earnings (18080)
Editorial (6)
Employer resources (28)
Events (24884)
Executive appointments (346)
FDA (6472)
Funding (514)
Gene editing (51)
Generative AI (19)
Gene therapy (131)
GLP-1 (159)
Government (794)
Grass and pollen (2)
Guidances (158)
Healthcare (6108)
HIV (29)
Huntington's disease (1)
IgA nephropathy (6)
Immunology and inflammation (14)
Immuno-oncology (9)
Indications (38)
Infectious disease (594)
Inflammatory bowel disease (38)
Inflation Reduction Act (2)
Influenza (31)
Intellectual property (65)
Interviews (39)
IPO (4423)
IRA (5)
Job creations (527)
Job search strategy (213)
JPM (6)
Kidney cancer (1)
Labor market (15)
Layoffs (49)
Leadership (9)
Legal (1118)
Liver cancer (9)
Longevity (5)
Lung cancer (123)
Lymphoma (60)
Machine learning (22)
Management (13)
Manufacturing (354)
MASH (14)
Medical device (7291)
Medtech (7324)
Mergers & acquisitions (6980)
Metabolic disorders (209)
Multiple sclerosis (28)
Neurodegenerative disease (60)
Neuropsychiatric disorders (8)
Neuroscience (577)
NextGen: Class of 2026 (2436)
Non-profit (1055)
Now hiring (8)
Obesity (75)
Opinion (59)
Ovarian cancer (24)
Pain (146)
Pancreatic cancer (44)
Parkinson's disease (60)
Partnered (18)
Patents (140)
Patient recruitment (114)
Peanut (17)
People (14754)
Pharmaceutical (9)
Pharmacy benefit managers (8)
Phase 1 (2034)
Phase 2 (3368)
Phase 3 (3753)
Pipeline (1427)
Policy (30)
Postmarket research (432)
Preclinical (912)
Press Release (19)
Prostate cancer (55)
Psychedelics (4)
Radiopharmaceuticals (71)
Rare diseases (145)
Real estate (1740)
Recruiting (8)
Regulatory (5596)
Reports (13)
Research institute (639)
Resumes & cover letters (47)
Rett syndrome (7)
RNA editing (3)
RSV (14)
Schizophrenia (14)
Series A (84)
Series B (65)
Service/supplier (7)
Sickle cell disease (9)
Special edition (1)
Spinal muscular atrophy (16)
Sponsored (23)
Startups (830)
State (1)
Supply chain (50)
Tariffs (6)
Vaccines (173)
Venture capital (13)
Weight loss (45)
Women's health (42)
Worklife (4)
Date
Last 7 days (185)
Last 30 days (648)
Last 365 days (8324)
2026 (853)
2025 (8633)
2024 (10473)
2023 (11595)
2022 (17535)
2021 (18684)
2020 (18857)
2019 (16785)
2018 (12138)
2017 (9525)
2016 (8940)
2015 (9769)
2014 (7114)
2013 (6073)
2012 (6407)
2011 (6230)
2010 (4991)
Location
Africa (154)
Alabama (22)
Alaska (2)
Arizona (89)
Arkansas (4)
Asia (10014)
Australia (1223)
California (2803)
Canada (946)
China (248)
Colorado (195)
Connecticut (110)
Delaware (126)
Europe (26291)
Florida (513)
Georgia (192)
Hawaii (2)
Idaho (43)
Illinois (409)
India (38)
Indiana (324)
Iowa (9)
Japan (122)
Kansas (35)
Kentucky (13)
Louisiana (9)
Maine (29)
Maryland (329)
Massachusetts (1578)
Michigan (173)
Minnesota (328)
Mississippi (5)
Missouri (74)
Montana (19)
Nebraska (12)
Nevada (41)
New Hampshire (49)
New Jersey (1029)
New Mexico (17)
New York (617)
North Carolina (617)
North Dakota (8)
Northern California (1244)
Ohio (151)
Oklahoma (10)
Oregon (17)
Pennsylvania (632)
Puerto Rico (4)
Rhode Island (25)
South America (297)
South Carolina (51)
South Dakota (1)
Southern California (1099)
Tennessee (63)
Texas (476)
United States (11324)
Utah (101)
Vermont (1)
Virginia (84)
Washington D.C. (20)
Washington State (172)
West Virginia (2)
Wisconsin (89)
Wyoming (1)
193,708 Results for "analgesic solutions".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PVP Labs to Present TAPHALGIN® Tetrapeptide Analgesic Platform at JP Morgan Healthcare Conference 2026
January 13, 2026
·
3 min read
Press Releases
Pacira BioSciences Enters Exclusive License Agreement with AmacaThera for its Novel Long-acting Analgesic for Postsurgical Pain Control
November 5, 2025
·
7 min read
Venture capital
Ambros Launches With $125M To Bring Italian Non-Opioid Pain Drug to America
Ambros Therapeutics’ non-opioid bisphosphonate analgesic, already approved in Italy, will soon begin a pivotal test in the U.S.
December 16, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
The Chemo Mouthpiece® Medical Device Significantly Reduces Oral Pain and Opioid/Analgesic Use During Chemotherapy in Multi-Center Pivotal Clinical Trial
August 21, 2025
·
6 min read
Press Releases
Analgesics Market Size to Exceed USD 143.42 Billion by 2034 Rising Chronic Pain and Advancements in Pain Relief Treatments
July 10, 2025
·
1 min read
Press Releases
Agilent Showcases Next‑Generation Automated Solutions at SLAS2026
February 5, 2026
·
4 min read
Press Releases
Piramal Pharma Solutions Introduces Tablet-in-Capsule Capabilities
February 3, 2026
·
5 min read
Press Releases
HighLife Receives CE Mark Approval for its TMVR Solution
January 26, 2026
·
4 min read
Sponsored
Accelerating Timelines and Reducing Cost in Early Clinical Drug Development With ICON’s Accelerated Pharmaceutical Solutions
Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced formulation design, real-time dose flexibility, and cutting-edge CMC expertise to transform complexity into clarity. By uniting science, technology, and strategy, biotechs can move faster, smarter, and with confidence—turning obstacles into opportunities for breakthrough success.
December 8, 2025
·
5 min read
·
Arjen Akkerman
Press Releases
FDA Clears Toetal Solution’s Ziptoe Hammertoe System
January 8, 2026
·
3 min read
1 of 19,371
Next
